| Institutions |
Authors |
Share |
|
F. Hoffmann-La Roche Ltd., Switzerland
|
9.000000
|
0.35 |
|
Roche Products Limited, United Kingdom (UK)
|
1.000000
|
0.04 |
|
The University of Texas MD Anderson Cancer Center, United States of America (USA)
|
1.000000
|
0.04 |
|
IRCCS Istituto Nazionale Tumori IRCCS-Fondazione G. Pascale, Italy
|
1.000000
|
0.04 |
|
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)
|
1.000000
|
0.04 |
|
Institute Gustave-Roussy (IGR), France
|
1.000000
|
0.04 |
|
The Angeles Clinic and Research Institute, United States of America (USA)
|
1.000000
|
0.04 |
|
Hospital Timone, France
|
1.000000
|
0.04 |
|
Vall d'Hebron University Hospital (HUVH), ICS, Spain
|
1.000000
|
0.04 |
|
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France
|
1.000000
|
0.04 |
|
Roche Deutschland Holding GmbH, Germany
|
1.000000
|
0.04 |
|
The University of Sydney (USYD), Australia
|
0.900000
|
0.03 |
|
Melanoma Institute Australia, Australia
|
0.700000
|
0.03 |
|
Royal North Shore Hospital (RNSH), Australia
|
0.500000
|
0.02 |
|
Mater Hospital North Sydney, Australia
|
0.500000
|
0.02 |
|
Institut de Recherche Saint-Louis (IRSL), France
|
0.500000
|
0.02 |
|
Génome, Biologie cellulaire et Thérapeutique (GenCellDi), France
|
0.500000
|
0.02 |
|
IRCCS European Institute of Oncology (IEO), Italy
|
0.500000
|
0.02 |
|
University of Milan (UNIMI), Italy
|
0.500000
|
0.02 |
|
University Hospital "Santa Maria della Misericordia", Italy
|
0.500000
|
0.02 |
|
University of Perugia, Italy
|
0.500000
|
0.02 |
|
Netherlands Cancer Institute (NKI), Netherlands
|
0.333333
|
0.01 |
|
Leiden University Medical Center (LUMC), Netherlands
|
0.333333
|
0.01 |
|
University Hospital of Regensburg (UKR), Germany
|
0.333333
|
0.01 |
|
Royal Prince Alfred Hospital (RPAH), USYD, Australia
|
0.200000
|
0.01 |
|
NSW Health Pathology, Australia
|
0.200000
|
0.01 |
